Letter to the Editor
Long-term efficacy of rituximab in chronic ataxic neuropathy associated with anti-ganglioside antibodies
Eficacia a largo plazo del rituximab en la neuropatía crónica atáxica con anticuerpos antigangliósidos
Read
3200
Timeswas read the article
482
Total PDF
2718
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 December | 39 | 7 | 46 |
| 2024 November | 52 | 5 | 57 |
| 2024 October | 71 | 20 | 91 |
| 2024 September | 67 | 17 | 84 |
| 2024 August | 58 | 18 | 76 |
| 2024 July | 52 | 4 | 56 |
| 2024 June | 86 | 13 | 99 |
| 2024 May | 85 | 4 | 89 |
| 2024 April | 83 | 8 | 91 |
| 2024 March | 97 | 17 | 114 |
| 2024 February | 161 | 25 | 186 |
| 2024 January | 104 | 15 | 119 |
| 2023 December | 109 | 15 | 124 |
| 2023 November | 80 | 15 | 95 |
| 2023 October | 116 | 14 | 130 |
| 2023 September | 62 | 4 | 66 |
| 2023 August | 57 | 10 | 67 |
| 2023 July | 83 | 6 | 89 |
| 2023 June | 41 | 8 | 49 |
| 2023 May | 174 | 13 | 187 |
| 2023 April | 64 | 8 | 72 |
| 2023 March | 127 | 9 | 136 |
| 2023 February | 50 | 14 | 64 |
| 2023 January | 77 | 16 | 93 |
| 2022 December | 59 | 5 | 64 |
| 2022 November | 67 | 9 | 76 |
| 2022 October | 85 | 12 | 97 |
| 2022 September | 38 | 7 | 45 |
| 2022 August | 71 | 15 | 86 |
| 2022 July | 60 | 13 | 73 |
| 2022 June | 59 | 9 | 68 |
| 2022 May | 38 | 16 | 54 |
| 2022 April | 31 | 10 | 41 |
| 2022 March | 41 | 8 | 49 |
| 2022 February | 30 | 18 | 48 |
| 2022 January | 41 | 7 | 48 |
| 2021 December | 33 | 11 | 44 |
| 2021 November | 40 | 13 | 53 |
| 2021 October | 14 | 14 | 28 |
| 2021 September | 8 | 16 | 24 |
| 2021 August | 5 | 10 | 15 |
| 2021 July | 3 | 4 | 7 |
Show all
